Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 8CNS 4Thoracic 3Sarcoma 2Gynecologic 2Genitourinary 2Other 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Xerostomia 1Squamous Cell Carcinoma of Head and Neck 1Mucositis 1Head and Neck Neoplasms 1

Interventions

Cisplatin 4Radiotherapy 3Radiation 3Amifostine 2pegfilgrastim 1Vaccinium myrtillus extract 1Tramadol 1Surgical Procedures, Operative 1Selenomethionine 1Radiotherapy, Intensity-Modulated 1Paclitaxel 1Neck Dissection 1Lysine 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Filgrastim 1Fibroblast Growth Factor 7 1Doxepin 1Docetaxel 1Carboplatin 1CBLB502 1Buprenorphine 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Filgrastim × Other × Clear all
NCT00352118 2017-12-28

Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
4 enrolled 4 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Xerostomia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡